Baudax Bio Inc reports results for the quarter ended in September - Earnings Summary

Baudax Bio

04/11/2021 17:53

* Baudax Bio Inc  BXRX.OQ  reported a quarterly adjusted loss
of 20 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 15 cents per share.
* Revenue rose 313.2% to $281.00 thousand from a year ago; 
analysts expected $600.00 thousand. 
* Baudax Bio Inc's reported EPS for the quarter was a loss of 20
cents​.
* The mean earnings estimate of analysts had risen by
about 10.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Baudax Bio Inc shares had held steady so far this quarter and
lost 44.2% so far this year.
* The company reported a quarterly loss of $16.96 million.
* Wall Street's median 12-month price target for Baudax Bio Inc
is $2.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 4 at 05:53 p.m.
 ​All figures in US dollars unless otherwise stated